Adam Lezack's most recent trade in Beta Bionics Inc. was a trade of 906 Common Stock done at an average price of $29.3 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc | Adam Lezack | Director | Sale of securities on an exchange or to another person at price $ 29.35 per share. | 01 Dec 2025 | 906 | 8,935 | - | 29.3 | 26,588 | Common Stock |
| Beta Bionics Inc | Adam Lezack | Director | Sale of securities on an exchange or to another person at price $ 29.91 per share. | 01 Dec 2025 | 500 | 8,435 | - | 29.9 | 14,955 | Common Stock |
| Beta Bionics Inc | Adam Lezack | Director | Sale of securities on an exchange or to another person at price $ 26.85 per share. | 31 Oct 2025 | 1,368 | 9,879 | - | 26.8 | 36,727 | Common Stock |
| Beta Bionics Inc | Adam Lezack | Director | Sale of securities on an exchange or to another person at price $ 27.71 per share. | 31 Oct 2025 | 38 | 9,841 | - | 27.7 | 1,053 | Common Stock |
| Beta Bionics Inc | Adam Lezack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Beta Bionics Inc | Adam Lezack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 9,137 | 9,137 | - | - | Director Stock Option (right to buy) |